Patent · US Active

Vaccines against Toxoplasma gondii

US9408899B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignees

THE UNIVERSITY OF CHICAGO · US
INFECTIOUS DISEASE RESEARCH INSTITUTE · US
Paxvax, Inc. · US

Inventors

Rima McLeod · Chicago, US
Tze Guan Tan · Cambridge, US
Jeffery L. Alexander · San Diego, US
Hua Cong · Shandong, CN
William H. Witola · Auburn, US
Kamal El Bissati · Chicago, US
Ernest Mui · Chicago, US
Steven G. Reed · Bellevue, US

Key dates

Filing date	Nov 3, 2011
Grant date	Aug 9, 2016
Priority date	—
Expiry date	Nov 3, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6031
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Vaccines are disclosed against parasites. The vaccines include peptides in an immunological composition. In particular, the parasite is Toxoplas gondii.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.